FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $559,000 | -62.6% | 24,946 | -2.2% | 0.10% | -38.5% |
| Q4 2021 | $1,493,000 | +47.4% | 25,513 | +49.2% | 0.16% | +47.7% |
| Q3 2021 | $1,013,000 | -48.5% | 17,099 | -24.5% | 0.11% | -48.6% |
| Q2 2021 | $1,966,000 | +7.7% | 22,647 | +2.3% | 0.21% | +2.4% |
| Q1 2021 | $1,826,000 | -18.1% | 22,144 | -9.7% | 0.21% | -19.8% |
| Q4 2020 | $2,230,000 | +105.7% | 24,519 | -9.6% | 0.26% | +73.2% |
| Q3 2020 | $1,084,000 | +42.1% | 27,121 | +21.9% | 0.15% | +30.7% |
| Q2 2020 | $763,000 | +88.4% | 22,242 | +22.0% | 0.11% | +50.0% |
| Q1 2020 | $405,000 | – | 18,230 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |